HCA Healthcare in talks to sell portion of Sarah Cannon to pharmaceutical giant


The deal would likely work as a joint venture between HCA and US Oncology, according to two sources, specifically involving the research arm of Sarah Cannon.

Previous San Antonio-headquartered Victory Capital reports $6B increase in assets since last year
Next Emerging Leaders: To stay on top of mental health in the workplace, prioritize personal engagement